19
Views
18
CrossRef citations to date
0
Altmetric
Original Article

Cyclosporin for Inflammatory Bowel Disease: Mechanisms and Possible Actions

Pages 849-857 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Peter Rolny & Morten Vatn. (2013) Cyclosporine in patients with severe steroid refractory ulcerative colitis in the era of infliximab. Review article.. Scandinavian Journal of Gastroenterology 48:2, pages 131-135.
Read now
J. Brynskov & S. Nørby Rasmussen. (1996) Clinical Pharmacology in Gastroenterology: Development of New Forms of Treatment of Inflammatory Bowel Disease. Scandinavian Journal of Gastroenterology 31:sup216, pages 175-180.
Read now

Articles from other publishers (16)

Hideyuki Sato, Yuuki Kaneko, Kohei Yamada, Kurt D. Ristroph, Hoang D. Lu, Yoshiki Seto, Hak-Kim Chan, Robert K. Prud’homme & Satomi Onoue. (2020) Polymeric Nanocarriers With Mucus-Diffusive and Mucus-Adhesive Properties to Control Pharmacokinetic Behavior of Orally Dosed Cyclosporine A. Journal of Pharmaceutical Sciences 109:2, pages 1079-1085.
Crossref
Elena Toscano, Judit Cotta, Mercedes Robles, Ma Isabel Lucena & Raúl J. Andrade. (2010) Toxicidad hepática inducida por los nuevos fármacos inmunosupresores. Gastroenterología y Hepatología 33:1, pages 54-65.
Crossref
O. Watanabe, T. Ando, E.M. El-Omar, M. Shimada, K. Ina, K. Ishiguro, M. Hasegawa, N. Miyake, M. Nakamura, R. Miyahara, N. Ohmiya, Y. Niwa & H. Goto. (2009) Role of endoscopic ultrasonography in predicting the response to cyclosporin A in ulcerative colitis refractory to steroids. Digestive and Liver Disease 41:10, pages 735-739.
Crossref
B. Castro, J. Crespo, C. García-Suárez, E. Fábrega, F. Casafont & F. Pons-Romero. (2004) Triple terapia inmunosupresora en el tratamiento de la colitis ulcerosa grave. Gastroenterología y Hepatología 27:1, pages 1-5.
Crossref
E. Musch, T. Andus & M. Malek. (2002) Induction and maintenance of clinical remission by interferon‐β in patients with steroid‐refractory active ulcerative colitis—an open long‐term pilot trial. Alimentary Pharmacology & Therapeutics 16:7, pages 1233-1239.
Crossref
R. N. Cunliffe & B. B. Scott. (2002) Monitoring for drug side‐effects in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 16:4, pages 647-662.
Crossref
S.M. Madsen, P. Schlichting, B. Davidsen, O.H. Nielsen, B. Federspiel, P. Riis & P. Munkholm. (2001) An open-labeled, randomized study comparing systemic interferon-alpha-2A and prednisolone enemas in the treatment of left-sided ulcerative colitis. The American Journal of Gastroenterology 96:6, pages 1807-1815.
Crossref
Zheng-Rong Lu, Song-Qi Gao, Pavla Kopečková & Jindřich Kopeček. (1999) Synthesis of Bioadhesive Lectin-HPMA Copolymer−Cyclosporin Conjugates. Bioconjugate Chemistry 11:1, pages 3-7.
Crossref
Anthony J. ThomasJr.Jr. & Dominick J. CarboneJr.Jr.. 1999. Operative Strategies in Inflammatory Bowel Disease. Operative Strategies in Inflammatory Bowel Disease 465 473 .
Stack, Long & Hawkey. (1998) Short- and long-term outcome of patients treated with cyclosporin for severe acute ulcerative colitis. Alimentary Pharmacology & Therapeutics 12:10, pages 973-978.
Crossref
J. Ramakrishna, N. Langhans, K. Calenda, R. J. Grand & M. Verhave. (1996) Combined Use of Cyclosporine and Azathioprine or 6-Mercaptopurine in Pediatric Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology &amp Nutrition 22:3, pages 296-302.
Crossref
Guido AdlerGuido Adler. 1996. Morbus Crohn - Colitis ulcerosa. Morbus Crohn - Colitis ulcerosa 189 214 .
Stephen B. Hanauer & Michael I. Schulman. (1995) NEW THERAPEUTIC APPROACHES. Gastroenterology Clinics of North America 24:3, pages 523-540.
Crossref
I. Kirman, O. H. Nielsen, E. Kjaersgaard & J. Brynskov. (1995) Interleukin-2 receptor α and β chain expression by circulating αβ and γδ T cells in inflammatory bowel disease. Digestive Diseases and Sciences 40:2, pages 291-295.
Crossref
O. H. Nielsen, E. Langholz, J. Hendel & J. Brynskov. (1994) Circulating soluble intercellular adhesion molecule-1 (sICAM-1) in active inflammatory bowel disease. Digestive Diseases and Sciences 39:9, pages 1918-1923.
Crossref
F. Shanahan, G. C. O’Sullivan & J. K. Collins. 1994. Inflammatory Bowel Disease. Inflammatory Bowel Disease 367 373 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.